Trademark: 97581122
Status Date
Tuesday, July 4, 2023
Registration Number
7100849
Registration Date
Tuesday, July 4, 2023
Filing Date
Wednesday, September 7, 2022
Published for Opposition
Tuesday, April 18, 2023
44 Medical laboratory testing services for diagnostic or treatment purposes that enables DNAbased nextgeneration sequencing (NGS) testing to detect lymphoproliferative disorders and serve as molecular markers of malignant B or T cells
Jul 4, 2023
Notice Of Registration Confirmation Emailed
Jul 4, 2023
Registered-Principal Register
Apr 18, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 18, 2023
Published For Opposition
Mar 29, 2023
Notification Of Notice Of Publication E-Mailed
Mar 14, 2023
Notice Of Acceptance Of Amendment To Allege Use E-Mailed
Mar 12, 2023
Approved For Pub - Principal Register
Mar 12, 2023
Use Amendment Accepted
Feb 10, 2023
Teas/Email Correspondence Entered
Feb 9, 2023
Correspondence Received In Law Office
Feb 9, 2023
Teas Response To Office Action Received
Feb 10, 2023
Amendment To Use Processing Complete
Feb 10, 2023
Use Amendment Filed
Feb 9, 2023
Teas Amendment Of Use Received
Feb 3, 2023
Notification Of Non-Final Action E-Mailed
Feb 3, 2023
Non-Final Action E-Mailed
Feb 3, 2023
Non-Final Action Written
Feb 1, 2023
Assigned To Examiner
Sep 25, 2022
New Application Office Supplied Data Entered
Sep 10, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
